M&A · Healthcare · Buyer's industry: Services-Medical Laboratories
Exact Sciences Corp to acquire PreventionGenetics
Announced Jan 10, 2022 · Closed Jan 10, 2022 · Private target
Deal value$190M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed
Transaction
- Acquirer
- Exact Sciences Corp (EXAS)
- Target
- PreventionGenetics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Jan 10, 2022
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- XMS Capital
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Services-Medical Laboratories